Required fields are marked with *

Verification code

Mavorixafor hydrochloride

{PARAM:[Name]}()
Category Human immunodeficiency Virus (HIV)
CAS 880549-30-4
Description AMD-070 hydrochloride is a potent and selective antagonist of CXCR4 with an IC50 value of 13 nM in a CXCR4 125I-SDF inhibition binding assay.
Quotation Now

Product Information

Synonyms 880549-30-4;AMD-070 hydrochloride;Mavorixafor HCl;AMD 070 hydrochloride;AMD-070 (hydrochloride);Mavorixafor (hydrochloride);Mavorixafor hydrochloride;(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine hydrochloride;N'-(1H-benzimidazol-2-ylmethyl)-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine hydrochloride;N1-(1H-Benzimidazol-2-ylmethyl)-N1-[(8S)-5,6,7,8-tetrahydro-8-quinolinyl]-1,4-butanediamine hydrochloride;N'-(1H-benzimidazol-2-ylmethyl)-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine;hydrochloride;CHEMBL4203190;DTXSID60856161;(8S)-N-(4-aminobutyl)-N-[(1H-1,3-benzodiazol-2-yl)methyl]-5,6,7,8-tetrahydroquinolin-8-amine hydrochloride;HY-50101C;MFCD23160058;AKOS024462826;AT31564;TS-08272;CS-0159212;(8S)-N-(4-AMINOBUTYL)-N-(1H-1,3-BENZODIAZOL-2-YLMETHYL)-5,6,7,8-TETRAHYDROQUINOLIN-8-AMINE HYDROCHLORIDE;(S)-N1-((1H-benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine trihydrochloride;N~1~-[(1H-Benzimidazol-2-yl)methyl]-N~1~-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine--hydrogen chloride (1/1);
IUPAC Name N'-(1H-benzimidazol-2-ylmethyl)-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine;hydrochloride
Molecular Weight 385.93
Molecular Formula C21H28ClN5
Canonical SMILES NCCCCN(CC1=NC2=CC=CC=C2N1)[C@H]3CCCC4=C3N=CC=C4.[H]Cl
InChI InChI=1S/C21H27N5.ClH/c22-12-3-4-14-26(15-20-24-17-9-1-2-10-18(17)25-20)19-11-5-7-16-8-6-13-23-21(16)19;/h1-2,6,8-10,13,19H,3-5,7,11-12,14-15,22H2,(H,24,25);1H/t19-;/m0./s1
InChIKey DBNMEMJSDAAGNZ-FYZYNONXSA-N
Solubility 10 mM in DMSO
Appearance Light yellow to yellow solid
Storage Please store the product under the recommended conditions in the Certificate of Analysis.

TAKE YOUR NEXT STEPS

Get Started With Our Industry Experience And Client-Centric Focus!

Talk to Us

Copyright © 2024 BOC Sciences. All rights reserved.